Syros Pharmaceuticals, Inc. (SYRS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 | Q2'20 | Q1'20 | Q4'19 |
|---|
| Cash from Operations | -20.69M | -29.67M | -31.1M | -18.57M | -31.86M | -22.39M | -36.9M | -31.08M | -35.79M | -26.18M | -30.02M | -22.97M | -28.13M | -26.45M | -21.99M | -29.92M | -15.26M | -12.43M | 246K | -10.6M |
| Operating CF Margin % | - | - | - | -4809.59% | -846.84% | -790.19% | -1249.19% | 568.56% | -919.74% | -417.11% | -549.06% | -294.4% | -493.72% | -512.48% | -455.56% | -525.07% | -398.51% | -389.93% | 10.34% | -2087.2% |
| Operating CF Growth % | 35.06% | -32.52% | 15.73% | 40.27% | 10.98% | 14.49% | -22.93% | -35.33% | -27.23% | 1.04% | -36.5% | 23.24% | -84.38% | -112.81% | -9039.02% | -182.22% | -35.91% | 31.32% | 101.21% | 23.23% |
| Net Income | -6.4M | -23.33M | -3.71M | -64.38M | -40.14M | -36.26M | -23.79M | -4.77M | -30.25M | -34.48M | -25.15M | -23.81M | -26.03M | -22.49M | -14.23M | -30.13M | -19.49M | -17.2M | -17.23M | -19.73M |
| Depreciation & Amortization | 325K | 331K | 334K | 279K | 612K | 650K | 638K | 770K | 724K | 726K | 747K | 773K | 765K | 749K | 731K | 768K | 767K | 757K | 743K | 898K |
| Stock-Based Compensation | 1.63M | 1.8M | 2.1M | 1.72M | 3.25M | 2.81M | 2.65M | 2.9M | 2.96M | 2.69M | 2.86M | 2.88M | 2.1M | 2.45M | 2.93M | 3.03M | 2.72M | 2.73M | 2.46M | 3.22M |
| Deferred Taxes | 0 | 0 | 0 | 8.08M | 6.06M | 2.47M | 0 | 0 | 0 | 0 | 0 | -2.46M | -1.73M | -4.59M | -7.67M | 375K | 0 | 0 | -49K | 0 |
| Other Non-Cash Items | -20.16M | -4.55M | -26.96M | 29.49M | 147K | 149K | -9.19M | -30.58M | -4.61M | 101K | -2.19M | 185K | 180K | 174K | 167K | 91K | 79K | 1.53M | 626K | 6.84M |
| Working Capital Changes | 3.91M | -3.92M | -2.86M | 6.26M | -1.79M | 7.79M | -7.2M | 594K | -4.6M | 4.79M | -6.29M | -526K | -3.41M | -2.75M | -3.92M | -4.06M | 662K | -245K | 13.69M | -1.83M |
| Change in Receivables | 0 | 0 | 0 | 1.67M | 91K | 9K | -71K | 77K | 522K | 889K | -203K | 653K | -1.46M | 445K | 7K | -5K | -701K | -2K | 20M | -20.16M |
| Change in Inventory | 0 | 0 | 0 | 29K | -91K | -9K | 71K | -77K | -522K | -889K | 0 | 0 | 0 | 0 | -1.68M | 586K | 0 | 1.66M | -4.76M | -928K |
| Change in Payables | 2.18M | -3.88M | -198K | 8.69M | -3.84M | 3.9M | -3.62M | 2.44M | -2M | 3.3M | -969K | -286K | 340K | -69K | 63K | -1.16M | 2.26M | -1.09M | -1.06M | 1.4M |
| Cash from Investing | 0 | 25.07M | -24.64M | 1.52M | 28.64M | 32.92M | -25.75M | 37.72M | 6.19M | 15.89M | 7.38M | -245K | -17.3M | -34.84M | -262K | -29K | -522K | 4.01M | 43.2M | 16.95M |
| Capital Expenditures | 0 | -29K | 0 | -38K | 0 | 1K | -235K | -674K | -328K | -111K | -128K | -245K | -310K | -428K | -262K | -29K | -522K | -988K | -1.8M | -8.16M |
| CapEx % of Revenue | - | - | - | 9.84% | - | 0.04% | 7.96% | -12.33% | 8.43% | 1.77% | 2.34% | 3.14% | 5.44% | 8.29% | 5.43% | 0.51% | 13.64% | 30.99% | 75.54% | 1605.71% |
| Acquisitions | -125K | 0 | 29K | 1.56M | 0 | -32.92M | 25.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 125K | 25.1M | 0 | 0 | 28.64M | 32.92M | -25.51M | 38.4M | 6.52M | 16M | 7.51M | 34.42M | -16.99M | -34.42M | 0 | 50M | 0 | 5M | 45M | 110K |
| Cash from Financing | 0 | 41K | -265K | 43.38M | -5K | 140K | -53K | -10.7M | 142.06M | -222K | -93K | 96K | -67K | 72K | 70.41M | 110.8M | 236K | 220K | 31.69M | 1.09M |
| Debt Issued (Net) | 0 | 0 | 0 | -3K | 0 | -4K | -53K | -75K | -374K | -72K | -70K | -69K | -67K | -65K | -64K | 19.86M | -61K | -74K | 19.66M | -56K |
| Equity Issued (Net) | 0 | 0 | 0 | 43.27M | 0 | 0 | 0 | -8.22M | 128.01M | 0 | 0 | 0 | -36K | 0 | 70.35M | 90.38M | 0 | 0 | 11.94M | 824K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -161K |
| Share Repurchases | 115K | 0 | 0 | 0 | 0 | 0 | 0 | 217K | -81K | 0 | 0 | 323K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 41K | -265K | 113K | -5K | 144K | 0 | -2.4M | 14.43M | -151K | -23K | 165K | 36K | 137K | 121K | 570K | 297K | 294K | 100K | 321K |
| Net Change in Cash | -20.69M | -4.56M | -56M | 27.31M | -3.22M | 10.68M | -62.7M | -4.07M | 112.47M | -10.51M | -22.73M | -23.12M | -45.49M | -61.23M | 48.16M | 80.85M | -15.54M | -8.2M | 75.14M | 7.44M |
| Free Cash Flow | -20.69M | -29.67M | -31.1M | -18.6M | -31.86M | -22.39M | -37.14M | -31.76M | -36.12M | -26.29M | -30.14M | -23.21M | -28.44M | -26.88M | -22.25M | -29.95M | -15.78M | -13.42M | -1.55M | -18.76M |
| FCF Margin % | - | - | - | -4819.43% | -846.84% | -790.15% | -1257.14% | 580.89% | -928.17% | -418.88% | -551.4% | -297.54% | -499.16% | -520.77% | -460.99% | -525.58% | -412.15% | -420.92% | -65.2% | -3692.91% |
| FCF Growth % | 35.06% | -32.53% | 16.26% | 41.42% | 11.79% | 14.85% | -23.19% | -36.8% | -27% | 2.21% | -35.47% | 22.5% | -80.24% | -100.33% | -1334.69% | -59.66% | -14.38% | 30.9% | 92.59% | -33.93% |
| FCF per Share | -0.53 | -0.76 | -0.80 | -0.63 | -1.14 | -0.80 | -1.33 | -1.14 | -3.84 | -4.12 | -4.78 | -3.69 | -4.52 | -4.28 | -3.63 | -4.88 | -3.45 | -2.94 | -0.35 | -4.27 |
| FCF Conversion (FCF/Net Income) | 3.23x | 1.27x | 8.39x | 0.29x | 0.79x | 0.62x | 2.47x | -1.13x | 1.70x | 0.74x | 1.27x | 0.96x | 1.08x | 1.18x | 1.55x | 0.99x | 0.78x | 0.72x | -0.01x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 231K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 0 |